RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New RSV vaccine study aims to unlock immune secrets
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new RSV vaccine in 60 adults aged 20 and older to learn how it helps the body build strong, lasting protection. Researchers will measure antibodies and immune cell responses to both major RSV types. The goal is to understand how special vaccine ingredients boos…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: NA • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 12:55 UTC
-
Can a pregnancy shot shield babies from RSV? brazil study aims to find out.
⭐️ VACCINE ⭐️ Not yet recruitingThis study will check how well the RSV vaccine (RSVpreF) works when given to pregnant women in Brazil. Researchers will follow about 5,000 babies up to 1 year old to see if the vaccine lowers their risk of getting sick enough to need hospital or doctor visits for RSV. The goal is…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Inova Medical • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 12:49 UTC
-
New RSV vaccine trial aims to protect women from respiratory virus
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests a new vaccine (MKK900) designed to protect against respiratory syncytial virus (RSV). It involves 120 healthy women aged 18 to 49. The main goal is to check the vaccine's safety and how well it triggers an immune response.
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:06 UTC
-
New pill could help babies breathe easier from RSV
Disease control Not yet recruitingThis study tests a new oral drug called zelicapavir for children aged 1 month to 3 years with RSV infection. About 150 children will receive either the drug or a placebo to see if it speeds up recovery and reduces symptoms. The goal is to provide a convenient treatment that can b…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New RSV shot for infants enters safety testing
Prevention Not yet recruitingThis study tests a new injection called SIBP-A16 in 36 premature and full-term infants under 1 year old. The goal is to check if it is safe and how the body processes it, as a way to prevent severe RSV infection. Infants will receive either the study drug, a placebo, or an active…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated Jun 10, 2026 13:29 UTC
-
One shot could shield indigenous kids from deadly RSV
Prevention Not yet recruitingThis study tests whether a single injection of an RSV-fighting antibody (nirsevimab) given at 6 months old can prevent RSV infections in Aboriginal and Torres Strait Islander children in the Northern Territory, who face high rates of severe RSV. About 1,000 infants will be random…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE4 • Sponsor: Menzies School of Health Research • Aim: Prevention
Last updated Jun 03, 2026 12:04 UTC